Edap Tms (NASDAQ:EDAP – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “hold” rating to a “sell” rating in a research note issued on Tuesday.
Separately, HC Wainwright reaffirmed a “buy” rating and set a $19.00 price objective on shares of Edap Tms in a report on Thursday, August 29th.
Read Our Latest Analysis on EDAP
Edap Tms Stock Performance
Edap Tms (NASDAQ:EDAP – Get Free Report) last issued its earnings results on Wednesday, August 28th. The medical equipment provider reported ($0.18) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.04). The firm had revenue of $16.97 million during the quarter, compared to the consensus estimate of $17.16 million. Edap Tms had a negative return on equity of 44.21% and a negative net margin of 34.92%. As a group, analysts anticipate that Edap Tms will post -0.6 EPS for the current fiscal year.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Redhawk Wealth Advisors Inc. bought a new position in shares of Edap Tms during the 3rd quarter valued at approximately $36,000. BNP Paribas Financial Markets raised its stake in shares of Edap Tms by 23.7% in the third quarter. BNP Paribas Financial Markets now owns 23,000 shares of the medical equipment provider’s stock valued at $59,000 after acquiring an additional 4,400 shares during the period. Virtu Financial LLC bought a new stake in shares of Edap Tms in the 1st quarter worth about $82,000. Orion Capital Management LLC boosted its stake in shares of Edap Tms by 10.4% during the 3rd quarter. Orion Capital Management LLC now owns 69,800 shares of the medical equipment provider’s stock worth $178,000 after purchasing an additional 6,600 shares during the period. Finally, Commonwealth Equity Services LLC grew its holdings in Edap Tms by 5.9% during the 2nd quarter. Commonwealth Equity Services LLC now owns 71,260 shares of the medical equipment provider’s stock valued at $388,000 after purchasing an additional 4,000 shares during the last quarter. Hedge funds and other institutional investors own 62.74% of the company’s stock.
About Edap Tms
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments.
Featured Articles
- Five stocks we like better than Edap Tms
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Trading Stocks: RSI and Why it’s Useful
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- What is the FTSE 100 index?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.